GREG ZANTE
CIK 1264949 · Chief Financial Officer · last filed 2026-01-05
GREG ZANTE is a Chief Financial Officer who has filed 24 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for VKTX, was dated Jan 5, 2026. Across all open-market trades the lifetime net is −$25.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.50M
3
24
-$25.77M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VKTX | Chief Financial Officer | 191,371 | $28.75 | $5.50M | -$25.34M | 16 | 2026-01-05 |
| Viking Therapeutics, Inc. (VKTXW) Delisted | Chief Financial Officer | 89,751 | $4.60 | $412.9K | $0 | 2 | 2021-01-19 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | VP, Finance & Administration | 0 | $0.18 | $0 | -$430.0K | 6 | 2008-03-12 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-05 | VKTX | Mixed | +15,388 | -$1.90M | EDGAR |
| 2025-10-28 | VKTX | Mixed | +4,932 | -$216.5K | EDGAR |
| 2025-07-03 | VKTX | Mixed | +3,401 | -$118.4K | EDGAR |
| 2025-01-06 | VKTX | Mixed | +15,891 | -$2.15M | EDGAR |
| 2024-10-28 | VKTX | Mixed | −37,686 | -$9.38M | EDGAR |
| 2024-07-31 | VKTX | Mixed | +12,198 | -$922.2K | EDGAR |
| 2024-05-03 | VKTX | Mixed | −32,507 | -$4.82M | EDGAR |
| 2024-03-27 | VKTX | Mixed | +15,057 | -$1.38M | EDGAR |
| 2024-03-04 | VKTX | Mixed | +11,574 | -$1.71M | EDGAR |
| 2024-01-04 | VKTX | Mixed | +20,340 | -$1.38M | EDGAR |